Search terms
Results 1 - 10 of 13 - ordered by :
Pages: 1 2

Jabbour R., Kawamoto H., Tanaka A., Pagnesi M., Mangieri A., Regazzoli D., Ancona M., Spartera M., Giannini F., Montorfano M., Latib A., Colombo A. AIMS The aim of this study was to report on the ...

Date : 06/05/2016 Item size : 32076 bytes

Pappalardo F., Ancona M., Montorfano M., Regazzoli D., Mangieri A., Giannini F., Alfieri O., Colombo A., Latib A. AIMS Pressure-controlled intermittent coronary sinus occlusion (PICSO) is effective ...

Date : 06/05/2016 Item size : 33114 bytes

Regazzoli D., Ancona M., Azzalini L., Pagnesi M., Montalto C., Jabbour R., Ruparelia N., Mangieri A., Giannini F., Montorfano M., Latib A., Colombo A. AIMS Cirrhotic patients undergoing cardiac ...

Date : 06/05/2016 Item size : 32222 bytes

Additionally, we observed an improvement in renal function (eGFR baseline 62.0±16.5 vs. follow-up 70.2±23.1 ml/min/m2, p=0.12) and improved hepatic congestion: bilirubin (1.47±0.8 vs. 1.01±0.7 ...

Date : 06/05/2016 Item size : 31065 bytes

Ruparelia N., Latib A., Buzzatti N., Giannini F., Figini F., Mangieri A., Regazzoli D., Stella S., Sticchi A., Kawamoto H., Tanaka A., Agricola E., Monaco F., Castiglioni A., Ancona M., Cioni M., ...

Date : 06/05/2016 Item size : 31202 bytes

Figini F., Regazzoli D., Porata G., Aurelio A., Mazzone P., Ancona M., Mangieri A., Trevisi N., Latib A., Giannini F., Della Bella P., Montorfano M., Colombo A. AIMS Percutaneous left atrial ...

Date : 06/05/2016 Item size : 32934 bytes

Net adverse clinical events (NACE) were defined as a composite endpoint including: all-cause mortality, stroke, myocardial infarction and life-threatening or major bleeding. At baseline, no ...

Date : 06/05/2016 Item size : 31690 bytes

Spartera M., Aurelio A., Jabbour R., Regazzoli D., Mangieri A., Ancona M., Montorfano M., Latib A., Giannini F., Colombo A. AIMS To evaluate the clinical efficacy of the Coronary Sinus (CS) Reducer ...

Date : 06/05/2016 Item size : 30873 bytes

Adjusted heparin dose administration may reduce the risk of potential overdosing in this frail population. [...]the aim of this study is to evaluate the impact of Activated Clotting Time ...

Date : 21/05/2013 Item size : 33208 bytes

Perkan A., Giannini F., Santangelo S., Cinquetti M., Pirozzi F., Peretti A., Morosin M., Barbati G., Vitrella G., Rakar S., Longaro F., Salvi A., Sinagra G. Aims: The risk of contrast induced ...

Date : 21/05/2013 Item size : 32405 bytes